Anti-Human CDH3 Polyclonal Antibody from ProteoGenix; catalogue ARO-A21985; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Human CDH3 Polyclonal Antibody, a highly effective tool for research targeting the CDH3 protein. This antibody is specifically designed to bind to the CDH3 protein, also known as P-cadherin, and is suitable for a variety of applications in the field of biotechnology.
The CDH3 protein is a member of the cadherin superfamily, which plays a crucial role in cell-cell adhesion and signaling. It is primarily expressed in epithelial tissues, and has been implicated in various physiological processes, including tissue development, wound healing, and tumor progression.
Our Anti-Human CDH3 Polyclonal Antibody is a valuable tool for studying the function of the CDH3 protein in various biological processes. It can be used for immunofluorescence, immunohistochemistry, and western blotting experiments, providing reliable and reproducible results.
One of the main applications of this antibody is in cancer research. The CDH3 protein has been shown to be overexpressed in various types of cancer, including breast, prostate, and ovarian cancer. By targeting the CDH3 protein, our antibody can help researchers gain a better understanding of its role in cancer development and progression.
Additionally, our Anti-Human CDH3 Polyclonal Antibody can also be used in tissue engineering studies. The CDH3 protein is involved in the formation of cell-cell adhesions, which are crucial for tissue organization and function. By targeting the CDH3 protein, our antibody can aid in the study of tissue development and regeneration.
In summary, our Anti-Human CDH3 Polyclonal Antibody is a reliable and versatile tool for researchers studying the CDH3 protein. Its high specificity and sensitivity make it suitable for a wide range of applications, particularly in cancer research and tissue engineering. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A21985. For research use only.
Target: CDH3; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: ELISA, IHC, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
CDH3 identifies cadherin 3 in Homo sapiens (Human). This target record connects NCBI Gene 1001, UniProtKB P22223 and related ABMIUM catalogue products.
